Gautam Borthakur

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AbbVie
    Topic:
    Consulting
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Lava Therapeutics
    Topic:
    Consulting
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Advisory Board
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bio Ascend
    Topic:
    Advisory Board
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Molecular Partners
    Topic:
    advisory board
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Advisory Board
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astex
    Topic:
    Research Support
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ryvu
    Topic:
    Research support
    Date added:
    07/18/2024
    Date updated:
    07/18/2024
    Relationship end date:
    12/31/2024
Return to 2024 Summit on Hematological Cancers